[Hormonal changes and clinical effects produced in patients treated with a delyed-action preparation of synthetic ACTH].
D015065:17-Hydroxycorticosteroids / Q000378:metabolism*; D015068:17-Ketosteroids / Q000652:urine*; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009401:Nephrosis / Q000188:drug therapy*; D011693:Purpura / Q000188:drug therapy*; D014581:Urticaria / Q000188:drug therapy*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000324:Adrenocorticotropic Hormone
Modificazioni ormonali ed effetti clinici occorrenti in pazienti trattati con un preparato deposito di ACTH sintetico.